ロード中...
The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
SIMPLE SUMMARY: Due to the lack of selectivity and the severe side-effects, cytostatics are the drugs of the present but not of the future and consequently new anticancer strategies must be developed. After binding to the neurokinin-1 receptor (NK-1R), NK-1R antagonists exert antitumor actions (anti...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564414/ https://ncbi.nlm.nih.gov/pubmed/32962202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092682 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|